1. Dickinson DF, Arnold R, Wilkinson JL. Congenital heart disease among 160 48 liveborn children in Liverpool 1960 to 1969. Implications for surgical treatment. Heart. 1981;46:55–62.
2. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. JAC. 2002;39:1890–1900.
3. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation. 1971;43:323–332.
4. Park MK. Pediatric Cardiology for Practitioners. 5 ed. Mosby Elsevier; 2008.
5. Schwerzmann M, Pfammatter J-P. Approaching Atrial Septal Defects in Pulmonary Hypertension. Expert Review of Cardiovascular Therapy. 2015;13:693–701.
6. Nashat H, Montanaro C, Li W, Kempny A, Wort SJ, Dimopoulos K, Gatzoulis MA, Babu-Narayan SV. Atrial septal defects and pulmonary arterial hypertension. J Thorac Dis. 2018;10:S2953–S2965.
7. Dalvi B, Jain S, Pinto R. Device Closure of Atrial Septal Defect with Severe Pulmonary Hypertension in Adults: Patient Selection with Early and Intermediate Term Results. 2019;93:309–315.
8. Vyas-Read S, Guglani L, Shankar P, Travers C, Kanaan U. Atrial Septal Defects Accelerate Pulmonary Hypertension Diagnoses in Premature Infants. Frontiers in Pediatrics. 2018;6:1–10.
9. Engelfriet P, Meijboom F, Boersma E, Tijssen J, Mulder B. Repaired and Open Atrial Septal Defects Type II in Adulthood: An Epidemiological Study of a Large European Cohort. International Journal of Cardiology. 2008;126:379–385.
10. Geva T, Martins JD, Wald RM. Atrial Septal Defects. Lancet. 2014;383:1921– 1932.
11. Rana BS. Echocardiography guidance of atrial septal defect closure. J Thorac Dis. 2018;10:S2899–S2908.
12. Takaya Y, Taniguchi M, Akagi T, Nobusada S, Kusano K, Ito H, Sano S. Long- Term Effects of Transcatheter Closure of Atrial Septal Defect on Cardiac Remodelling and Exercise Capacity in Patients Older than 40 Years with a Reduction in Cardiopulmonary Function. Journal of Interventional Cardiology. 2013;26:195–199.
13. Helgason H, Jonsdottir G. Spontaneous Closure of Atrial Septal Defects. Pediatric Cardiology. 1999;20:195–199.
14. Anderson RH, Baker EJ, Penny D, Redington AN, Rigby ML, Wernovsky G. Paediatric Cardiology. 3rd ed. Churchill Livingstone Elsevier; 2009.
15. Baumgartner H, Bonhoeffer P, De Groot NMS, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJM, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E, ESC Committee for Practice Guidelines (CPG), Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Document Reviewers:, McDonagh T, Swan L, Andreotti F, Beghetti M, Borggrefe M, Bozio A, Brecker S, Budts W, Hess J, Hirsch R, Jondeau G, Kokkonen J, Kozelj M, Kucukoglu S, Laan M, Lionis C, Metreveli I, Moons P, Pieper PG, Pilossoff V, Popelova J, Price S, Roos- Hesselink J, Uva MS, Tornos P, Trindade PT, Ukkonen H, Walker H, Webb GD, Westby J. Endorsed by the Association for European Paediatric Cardiology (AEPC). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). European Heart Journal. 2010;31:2915–2957.
16. Murphy JG, Gersh BJ, McGoon M, Mair DD, Porter C-BJ, Ilstrup DM, McGoon DC, Puga FJ, Kirklin JW, Danielson GK. Long-term outcome after surgical repair of isolated atrial septal defect. the New England Journal of Medicine. 1990;323:1645–1650.
17. Horvath KA, Burke RP, Collins JJ, Cohn LH. Surgical Treatment of Adult Atrial Septal Defect: Early and Long- Term Results. JAC. 1992;20:1156–1159.
18. Du Z-D, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison Between Transcatheter and Surgical Closure of Secundum Atrial Septal Defect in Children and Adults. Journa of the American College of Cardiology. 2002;39:1836–1844.
19. Brida M, Diller G-P, Kempny A, Drakopolou M, Shore D, Gatzoulis MA, Uebing A. Atrial Septal Defect Closure in Adulthood is Associated with Normal Survival in the Mid to Longer Term. Heart. 2019;0:1–6.
20. Rome JJ, Keane JF, Perry SB, Spevak PJ, Lock JE. Double-umbrella closure of atrial defects. Initial clinical applications. Circulation. 1990;82:751–758.
21. Bissessor N. Current perspectives in percutaneous atrial septal defect closure devices. MDER. 2015;8:297–7.
22. McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects. Circulation. 2016;133:1738–1746.
23. Houeijeh A, t SH, Bouvaist HLN, Hadeed K, Petit JRM, Godart FO, Fraisse A. Transcatheter closure of large atrial septal defects (ASDs) in symptomatic children with device/weight ratio >1.5. International Journal of Cardiology. 2018;267:84–87.
24. Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberi A, Po EG, Bossone E, Frigiola A. Percutaneous Versus Surgical Closure of Secundum Atrial Septal Defect: Comparison of Early Results and Complications. American Journal of Cardiology. 2006;151:228–234.
25. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JEJ. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. The Journal of Thoracic and Cardiovascular Surgery. 2009;137:1334– 1341.
26. Kutty S, Hazeem AA, Brown K, Danford CJ, Worley SE, Delaney JW, Danford DA, Latson LA. Long-Term (5- to 20-Year) Outcomes After Transcatheter or Surgical Treatment of Hemodynamically Significant Isolated Secundum Atrial Septal Defect. AJC. 2012;109:1348–1352.
27. El-Said H, Hegde S, Foerster S, Hellenbrand W, Kreutzer J, Trucco SM, Holzer R, Burch G, Mirani A, Nicolas R, Porras D, Bergersen L, Moore J. Device Therapy for Atrial Septal Defects in a Multicenter Cohort. Cathet Cardiovasc Intervent. 2014;85:227–233.
28. Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B. Short and Long Term Complications of Device Closure of Atrial Septal Defect and Patent Foramen Ovale: Metaanalysis of 28,142 Patients from 203 studies. Cathet Cardiovasc Intervent. 2013;82:1123–1138.
29. Management of Cardiac Arrhythmias. Humana Press; 2007.
30. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NAM, Ferguson TB, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD. 2012 ACCF/AHA/HRS Focused Update IncorporatedInto the ACCF/AHA/HRS 2008 Guidelines forDevice-Based Therapy of Cardiac Rhythm Abnormalities. JAC. 2013;61:e6–e75.
31. Weindling SN, Saul PJ, Gamble WJ, Mayer JE, Wessel D, Walsh EP. Duration of Complete Atrioventricular Block After Congenital Heart Disease Surgery. The American Journal of Cardiology. 1998;82:525–527.
32. Krongrad E. Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation. 1978;57:867–870.
33. Gross GJ, Chiu CC, Hamilton RM, Kirsh JA, Stephenson EA. Natural history of postoperative heart block in congenital heart disease: Implications for pacing intervention. Heart Rhythm. 2006;3:601–604.
34. Brandenburg ROJ, Holmes DRJ, Brandenburg RO, McGoon DC. Clinical Follow-Up Study of Paroxysmal Supraventricular Tachyarrhythmias After Operative Repair of a Secundum Type Atrial Septal Defect in Adults. The American Journal of Cardiology. 1983;51:273–276.
35. Hayes CJ, Gersony WM. Arrhythmias After the Mustard Operation for Transposition of the Great Arteries: A Long-Term Study. Journal of american college of cardiology. 1986;7:133–137.
36. Martin RP, Radley-Smith R, Magdi YH. Arrhythmias Before and After Anatomic Correction of Transposition of the Great Arteries. Journal of american college of cardiology. 1987;10:200–204.
37. Driscoll DJ, Offord KP, Heldt RH, Schaff HV, Puga FJ, Danielson GK. Five- to Fifteen-Year Follow-up After Fontan Operation. Circulation. 1992;:469–496.
38. Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Davis A, Harris L, Gow RM, Williams WG, Trusler GA, Freedom RM. Arrhythmia and Mortality After the Mustard Procedure: A 30-year Single-Center Experience. Journal of american college of cardiology. 1996;29:194–201.
39. Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burneett J, Mayer JEJ, Walsh EP. Factors that Influence the Development of Atrial Flutter after the Fontan Operation. J Thorac Cardiovasc Surg. 1997;:80–86.
40. Williams MR, Perry JC. Arrhythmias and Conduction Disorders Associated with Atrial Septal Defects. J Thorac Dis. 2018;10:S2940–S2944.
41. Houck CA, Evertz R, Teuwen CP, Roos-Hesselink JW, Duijnhouwer T, Bogers AJJC, de Groot NMS. Time course and interrelationship of dysrhythmias in patients with surgically repaired atrial septal defect. Heart Rhythm. 2018;15:341– 347.
42. Loomba RS, Chandrasekar S, Sanan P, Shah PH, Arora RR. Association of Atrial Tachyarrhythmias with Atrial Septal Defect, Ebstein’s Anomaly and Fontan Patients. Expert Review of Cardiovascular Therapy. 2014;9:887–893.
43. Morton JB, Sanders P, Vohra JK, Sparks PB, Morgan JG, Spence SJ, Grigg LE, Kalman JM. Effect of Chronic Right Atrial Stretch on Atrial Electrical Remodeling in Patients With an Atrial Septal Defect. Circulation. 2003;107:1775–1782.
44. Schenck MH, Sterba R, Foreman CK, Latson LA. Improvement in noninvasive electrophysiologic findings in children after transcatheter atrial septal defect closure. The American Journal of Cardiology. 1995;76:695–698.
45. Berger F, Vogel M, Kramer A, Alexi-Meskishvili V, Weng Y, Lange PE, Hetzer R. Incidence of Atrial Flutter/Fibrillation in Adults With Atrial Septal Defect Before and After Surgery. The Annals of Thoracic Surgery. 1999;68:75–78.
46. Walker RE, Mayer JE, Alexander ME, Walsh EP, Berul CI. Paucity of Sinus Node Dysfunction Following Repair of Sinus Venosus Defects in Children. The American Journal of Cardiology. 2001;87:1223–1226.
47. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pome G, Bossone E, Frigiola A. Early and Late Complications Associated with Transcatheter Occlusion of Secundum Atrila Septal Defect. Journal of the american College of Cardiology. 2002;39:1061–1065.
48. Johnson JN, Marquardt ML, Ackerman MJ, Asirvatham SJ, Reeder GS, Cabalka AK, Cetta F, Hagler DJ. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure. Cathet Cardiovasc Intervent. 2011;78:254–261.
49. Wang L, Li J, Yao R, Song S, Guo Z. Long-term follow-up of patients with P-R prolongation after catheter ablation of slow pathway for atrioventricular node re- entrant tachycardia. Archives of Medical Research. 2004;35:442–445.
50. Suda K, Raboisson M-J, Piette E, Dahdah NS, Miró J. Reversible atrioventricular block associated with closure of atrial septal defects using the amplatzer device. Journal of the american College of Cardiology. 2004;43:1677–1682.
51. Rijnbeek P. New normal limits for the paediatric electrocardiogram. European Heart Journal. 2001;22:702–711.
52. Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum- type atrial septal defect closure using Amplatzer septal occluders. Journal of the american College of Cardiology. 2005;45:505–507.
53. Wilson NJ, Smith J, Prommete B, O’Donnell C, Gentles TL, Ruygrok PN. Transcatheter Closure of Secundum Atrial Septal Defects with the Amplatzer Septal Occluder in Adults and Children—Follow-up Closure Rates, Degree of Mitral Regurgitation and Evolution of Arrhythmias. “Heart, Lung and Circulation.” 2008;17:318–324.
54. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of Results and Complications of Surgical and Amplatzer device Closure of Atrila Septal Defects. Journal of Thoracic and Cardiovascular Surgery. 1999;118:674–680.
55. Hijazi ZM. Catheter Closure of Atrial Septal and Ventricular Septal defects Using The Amplatzer Devices. “Heart, Lung and Circulation.” 2003;:63–72.
56. Sadiq M, Kazmi T, Rehman AU, Latif F, Hyder N, Qureshi SA. Device Closure of Atrial Septal Defect: Medium-Term Outcome with Special Reference to Complications. Cardiology in the Young. 2012;22:71–78.
57. Nehgme RA, Huddleston AR, Cheatham JP. Progression to Late Complete Atrioventricular Block Following Amplatzer Device Closure of Atrial Septal Defect in a Child. Pediatric Cardiology. 2008;30:367–370.
58. Hill SL, Berul CI, Patel H, Rhodes J, Supran S, Cao Q-L, Hijazi ZM. Early ECG Abnormalities Associated with Transcatheter Closure of Atrial Septal Defects Using the Amplatzer. Journal of Interventional Cardiac Electrophysiology. 2000;:469–474.
59. Cottens D, Van De Bruaene A, Troost E, Willems R, Moons P, Budts W. Influence of percutaneous transcatheter closure of an atrial septal defect on the atrioventricular conduction. Acta Cardiol. 2011;66:309–314.
60. Wang Y, Hua Y, Li L, Wang X, Qiao L, Shi X, Hua J, Qu Y, Mu D. Risk Factors and Prognosis of Atrioventricular Block After Atrial Septum Defect Closure Using the Amplatzer Device. Pediatric Cardiology. 2013;35:550–555.
61. Al-Anani SJ, Weber H, Hijazi ZM. Atrioventricular block after transcatheter ASD closure using the Amplatzer septal occluder: Risk factors and recommendations. Cathet Cardiovasc Intervent. 2009;75:767–772.
62. Clark JB, Chowdhury D, Pauliks LB, Weber HS. Resolution of Heart Block After Surgical Removal of an Amplatzer Device. ATS. 2010;89:1631–1633.
63. Hessling G, Hyca S, Brockmeier K, Ulmer HE. Cardiac Dysrhythmias in Pediatric Patients Before and 1 Year After Transcatheter Closure of Atrial Septal Defects Using the Amplatzer Septal Occluder. Pediatric Cardiology. 2003;24:259–262.
64. Vecht JA, Saso S, Rao C, Dimopoulos K, Grapsa J, Terracciano CM, Peters NS, Nihoyannopoulos P, Holmes E, Gatzoulis MA, Athanasiou T. Atrial Septal Defect Closure is Associated with a Reduced Prevalence of Atrial Tachyarrhythmia in the Short to Medium Term: a Systematic Review and Meta- analysis. Heart. 2010;96:1789–1797.